FreeStyle Libre 2
-
4.6
-
Developer
Abbott Diabetes Care Inc.
-
Category
Medical
-
Version
2.5.3
-
Android OS
Varies with device
-
Downloads
630M
-
Content rating
0
Pro
👍 FreeStyle Libre 2 - CA delivers convenient continuous glucose monitoring with quick sensor scans and clear trend arrows, giving users immediate glucose readings and directional insights. The 14-day sensor provides reliable, painless wear and frequent data points so users can monitor patterns, adjust insulin or lifestyle choices, and better manage daily glycemic control.
👍 FreeStyle Libre 2 - CA offers optional real-time high and low glucose alarms that alert users and caregivers immediately, preventing dangerous episodes. Customizable thresholds and vibrate or audible notifications provide discreet, reliable warnings whether at home or on the go, increasing safety and confidence for people living with diabetes and those supporting them.
👍 FreeStyle Libre 2 - CA organizes glucose history into actionable reports and trend analyses, helping users and clinicians spot patterns and optimize treatment. Easy sharing via LibreView and secure export options streamline remote care and consultations. Intuitive charts, time-in-range metrics, and weekly summaries support informed decision-making and improved long-term outcomes.
Con
👎 Bluetooth dropouts between the sensor and phone can cause missed readings and delayed glucose alerts. Users report intermittent pairing problems—especially in crowded wireless environments or on older phones—that can undermine reliability, requiring frequent re-pairing, rescans, or use of the standalone reader to recover lost data and ensure safety.
👎 Compatibility is limited to specific smartphones and OS versions, leaving many older or budget devices unsupported. That forces some users to upgrade phones, carry the separate Libre reader, or experience interrupted monitoring—adding unexpected expense and inconvenience for people who rely on their phone as the primary glucose display and alert source.
👎 Feature set and data flexibility are modest compared with other CGM platforms. The app lacks built-in insulin dosing calculators, has limited third-party integrations, and offers fewer advanced analytics for trend interpretation. Data export and sharing work, but clinicians and power users may find the reporting options too basic for in-depth remote care or research.
Screenshots
